SCHEMBL26050285

SCHEMBL26050285

CCN1CCC(C)(C(=O)Nc2ccc(C)cc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.49
RAB9A P51151 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
LMNA P02545 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
DRD2 P14416 1/20 0.47
POLB P06746 3/20 0.46
TP53 P04637 1/20 0.46
ATM Q13315 1/20 0.46
ALDH1A1 P00352 2/20 0.45
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM1 P11229 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21651967 0.87 DRD2 (0.60) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL13696944 0.83 TDP1 (0.53) NPC1RAB9ASMN1; SMN2LMNATDP1
SCHEMBL20148061 0.81 RAB9A (0.50) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL20148034 0.74 POLB (0.49) MEN1KMT2ALMNAPOLBTP53
SCHEMBL30074425 0.71 TDP1 (0.55) NPC1RAB9ALMNATDP1POLB
SCHEMBL13212255 0.71 NPC1 (0.50) NPC1RAB9ASMN1; SMN2LMNATDP1
SCHEMBL14349967 0.71 SPHK1 (0.48) NPC1RAB9ASMN1; SMN2POLB
SCHEMBL25504420 0.70 KDM4E (0.60) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL20069153 0.70 DRD2 (0.54) NPC1RAB9ASMN1; SMN2KMT2ALMNA
SCHEMBL25775264 0.70 MAPT (0.53) NPC1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023150203-A1 HDAC6 INHIBITORS AND USES THEREOF EIKONIZO THERAPEUTICS, INC. (US) 2023-08-10 WO disclosed